| NCT Number | NCT04949464 |
| Lead Sponsor | AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI) |
| Conditions | HIV Infection, Tobacco-Related Carcinoma |
| Enrollment | 100 participants |
| Start Date | 2023-03-22 |
| Primary Completion | 2026-08-31 (estimated) |
| Study Completion | 2027-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-05 |